Verastem Oncology
VSTM
#6451
Rank
S$1.15 B
Marketcap
S$12.74
Share price
-0.90%
Change (1 day)
12.58%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -S$0.27 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are S$87.52 Million. In 2025 the company made an earning of -S$0.27 Billion a decrease over its 2024 earnings that were of -S$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.27 Billion-3.03%
2025 -S$0.27 Billion60.57%
2024 -S$0.17 Billion49.31%
2023 -S$0.12 Billion18.36%
2022 -S$94.55 Million3.67%
2021 -S$91.2 Million5.43%
2020 -S$86.5 Million-54.74%
2019 -S$0.2 Billion105.99%
2018 -S$92.78 Million6.83%
2017 -S$86.85 Million86.06%
2016 -S$46.68 Million-37.03%
2015 -S$74.12 Million8.43%
2014 -S$68.36 Million29.52%
2013 -S$52.78 Million28.6%
2012 -S$41.04 Million133.9%
2011 -S$17.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.84 B-3,521.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$1.87 B-823.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$10.10 B-4,007.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-S$10.83 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA